InvestorsHub Logo
Followers 25
Posts 570
Boards Moderated 0
Alias Born 06/11/2011

Re: dstock07734 post# 629992

Tuesday, 09/12/2023 3:38:07 AM

Tuesday, September 12, 2023 3:38:07 AM

Post# of 716347
That's an interesting point that you raise:

..... in the UK special program [is] the regimen in use the DCVax-L + Poly-ICLC?


As the special program relates solely to the DCVax-L component, surely it is up to the responsible clinician to decide whether or not the patient should be subjected to any additional treatment, be it poly-ICLC, pembrolizumab or both.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News